The EGF Receptor System as a Target for Antitumor Therapy

References

• Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Ann Rev Biochem 1987; 56: 881–914
   PubMed Web of Science ®Google Scholar
• Carpenter G., Cohen S. Epidermal growth factor. Ann Rev Biochem 1979; 48: 193–216
   PubMed Web of Science ®Google Scholar
• Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in newborn animals. J Biol Chem. 1962; 237: 1555–1562
   PubMed Web of Science ®Google Scholar
• Todaro G. J., DeLarco J. E., Cohen S. Transformation by murine and feline sarwma viruses specifically blocks binding of epidermal growth factor to cells. Nature 1976; 264: 26–31
   PubMed Web of Science ®Google Scholar
• DeLarco J. E., Todaro G. J. Growth factors from murine sarcoma virus transformed cells. Proc Natl Ad Sci (USA) 1978; 75: 4001–4005
   PubMed Web of Science ®Google Scholar
• Derynck R., Roberts A. B., Winkler M. E., et al. Human transforming growth factor-α: precursor structure and expression in E. coli. Cell 1984; 38: 287–297
   PubMed Web of Science ®Google Scholar
• Hollenberg M., Cuatrecasas P. Epidermal growth factor: receptors in human fibroblasts and modulation of action by cholera toxin. Roc Natl Acad Sci (USA) 1973; 70: 2964–2968
   PubMed Web of Science ®Google Scholar
• Downward J., Yarden Y., Mayes E., et al. Close similarities of the EGF receptor and v-erbB oncogene protein sequences. Nature 1984; 307: 521–527
   PubMed Web of Science ®Google Scholar
• Ullrich A., Coussens I., Hayflick T., et al. Human epidermal growth factor receptor DNA sequence and abberant expression of the amplified gene in A431 epidermal carcinoma cells. Nature 1984; 309: 418–425
   PubMed Web of Science ®Google Scholar
• Hunter T., Cooper J. Rotein-tyrosine kinases. Annu Rev Biochem 1985; 54: 897–930
   PubMed Web of Science ®Google Scholar
• Schlessinger J. Allosteric regulation of the epidermal growth factor kinasc. J Cell Biol 1986; 1032: 2067–2072
   Google Scholar
• Schlessinger J. Signal transduction by allosteric receptor oligomerization. Trends Bochem 1988; 13: 443–447
   PubMed Web of Science ®Google Scholar
• Yarden Y., Ullrich A. Growth factor receptor tyrosine kinases. Annu Rev Biochem 1988; 57: 443–448
   PubMed Web of Science ®Google Scholar
• Honegger A. M., Szapary D., Schmidt A., et al. A mutant EGF recepor with defective protein tyrosine kinase is unable to stimulate protooncogene expression and DNA synthesis. Mol Cell Biol 1987; 7: 4568–4571
   PubMed Web of Science ®Google Scholar
• Yaish P., Gazit A., Gilon C., et al. Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors. Science 1988; 242: 933–935
   PubMed Web of Science ®Google Scholar
• Lyall R. M., Zilberstein A., Gazit A., et al. Tyrphostins inhibit epidermal growth factor (EGF)-receptor tyrosine kinase activity in living cells and EGF-stimulated cell proliferation. J Biol Chem 1989; 264: 14503–14509
   PubMed Web of Science ®Google Scholar
• Magolis B., Rhee S. G., Felder S., et al. EGF induces tyrosine phosphorylation of phosphlipase C-II: A potential mechanism of EGF receptor signaling. Cell 1989; 57: 1101–1107
   PubMed Web of Science ®Google Scholar
• Wahl M. I., Nishibe S., Suh P-G, et al. Epidermal growth factor stimulates tyrosine phosphorylation of phospholipase C-II independently of receptor internalization and extracellular calcium. Proc Natl Acad (USA) 1989; 86: 1568–1572
   PubMed Web of Science ®Google Scholar
• Velu T. J., Beguinot L., Vass W. C., et al. Epidermal growth factor-dependent transformation by a human EGF receptor protooncogene. Science 1987; 238: 1408–1410
   PubMed Web of Science ®Google Scholar
• DiFiore P. P., Pierce J. H., Fleming T. P., et al. Overexpression of the human EGF receptor confers an EGFdependent transformed phenotype to NIH 3T3 cells. Cells 1987; 51: 1063–1070
   PubMed Web of Science ®Google Scholar
• Libermann T. A., Nusbaum H. R., Razon N., et al. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 1985; 313: 144–147
   PubMed Web of Science ®Google Scholar
• Yamamoto T., Kamata N., Kawano H., et al. High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res 1986; 46: 414–416
   PubMed Web of Science ®Google Scholar
• Osborne C. K., Hamilton B., Nover M. Receptor binding and processing of epidermal growth factor by human breast cancer cells. J Clin Endocrinol Metab 1982; 55: 98–93
   Google Scholar
• Fitzpatrick S. L., LaChance M. P., Schultz G. S. Characterization of epidermal growth factor recepor and action on human breast cancer cells in culture. Cancer Res 1984; 44: 3442–3447
   PubMed Web of Science ®Google Scholar
• Filmus F., Pollak M. N., Cailleau R., et al. MDA-468 A human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem Biophys Res Comm 1985; 128: 898–905
   PubMed Web of Science ®Google Scholar
• Davidson N. E., Gelmann E. P., Lippman M. E., et al. Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Mol Endocrinol 1987; 1: 216–223
   PubMedGoogle Scholar
• Sainsbury J. R., Farndon J. R., Nedham G. K., et al. Epidermal-growthfactor receptor status as predictor of early recurrence of death from breast cancer. Lancet 1987; i: 1398–1402
   Google Scholar
• Perez R., Pascual M., Marcias A., et al. Epidermal growth factor receptors in human breast cancer. Breast Cancer Res Treat 1984; 4: 189–193
   PubMed Web of Science ®Google Scholar
• Hendler F., Ozanne B. Human squamous cell lung cancers express increased epidermal growth factor receptors. J Clin Invest 1984; 74: 647–651
   PubMed Web of Science ®Google Scholar
• Gullick W., Marsden J., Whittle N., et al. Expression on epidermal growth factors receptors on human cervical, ovarian, and vulvar carcinomas. Cancer Res 1986; 46: 285–292
   PubMed Web of Science ®Google Scholar
• Libbennan T., Razon N., Bartal A., et al. Expression of epidermal growth factor receptors in human tumors. Cancer Res 1984; 44: 753–760
   PubMed Web of Science ®Google Scholar
• Real F. X., Rettig W. J., Chesa P. G., et al. Expression of epidermal growth factor receptor in human cultured cells and tissues: relationship to cell lineage and stage of differentiation. Cancer Res 1986; 46: 4726–4731
   PubMed Web of Science ®Google Scholar
• Koprowski H., Herlyn M., Balaban G., et al. Expression of the receptor for epidermal growth factor correlates with increased dosage of chromosome 7 in malignant melanoma. Somatic Cell Mol Genet 1985; 11: 297–305
   PubMedGoogle Scholar
• Sainsburg J. RC, Farndon J. R., Sherbert V. G., et al. Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer. Lancet 1985; 1: 364–366
   PubMed Web of Science ®Google Scholar
• Neal D., Marsh C., Bennett M., et al. Epidermal growth factor raptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet 1985; 1: 366–368
   PubMed Web of Science ®Google Scholar
• Murphy L. C., Murphy L. J., Dubik D., et al. Epidermal growth factor gene expression in human breast cancer cells: regulation of expression by progestins. Cancer Res 1988; 48: 4555–4560
   PubMed Web of Science ®Google Scholar
• Marquardt J., Hunkapiller M. M., Hood L. E., et al. Transforming growth factors produced by retrovrius-transformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor. Proc Natl Acad Sci (USA) 1983; 80: 4684–4688
   PubMed Web of Science ®Google Scholar
• Todaro G. J., Fryling C., DeLarco J. E. Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Roc Natl Acad Sci (USA) 1980; 77: 5258–5262
   PubMed Web of Science ®Google Scholar
• Derynck R., Goeddel D. V., Ullrich A., et al. Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res 1987; 47: 707–712
   PubMed Web of Science ®Google Scholar
• Bates S. B., McManaway M. E., Lippman M. E., et al. Characterization of estrogen responsive transforming activity in human breast cancer cell lines. Cancer Res 1986; 46: 1707–1713
   PubMed Web of Science ®Google Scholar
• Bates S. E., Davidson N. E., Valverius E. M., et al. Expression of transforming growth factor α and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol Endocrinol 1988; 2543–555
   Google Scholar
• Arteaga C. L., Hanauske A. R., Clark G. M., et al. Immunoreactive α-transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis. Cancer Res 1988; 48: 5023–5028
   PubMed Web of Science ®Google Scholar
• Spom M. B., Todaro G. J. Autocrine secretion and malignant transfor-matio of cells. N Engl J Med 1980; 303: 878–880
   PubMed Web of Science ®Google Scholar
• Lippman M. E., Dickson R. B., Bates S., et al. Autocrine and paracrine growth regulation of human breast cancer. Breast Cancer Res Treat 1986; 7: 59–70
   PubMed Web of Science ®Google Scholar
• Ikeda T., Danielpour D., Sirbasku D. A. Isolation and properties of endocrine and autocrine type mammary tumor cell growth factors (estromedins). Progress in Cancer Research and Therapy, F. Bresciani, R. JB King, M. E. Lippman, et al. Raven Press, New York 1983; Vol. 316: 171–186
   Google Scholar
• Soto A. M., Sonnenschein C. Cell proliferation of attogen-sensitive cells: the case for negative growth control. Endo Rev 1987; 844–52
   Google Scholar
• Ennis B. W., Valverius E., Bates S. E., et al. Anti-epidermal growth factor receptor antibodies inhibit the autocrine stimulated growth of MDA-468 human breast cancer cells. Mol Endocrinol 1989; 3: 1830–1838
   PubMed Web of Science ®Google Scholar
• Bates S. E., Valverius E. M., Ennis B. W., et al. Expression of the transforming growth factor alepidermal growth factor receptor pathway in normal human breast epithelial cells. Endocrinology 1990; 126: 596–607
   PubMed Web of Science ®Google Scholar
• Dickson R. B., Lippman M. E. Estrogenic regulation of growth and polypetide growth factor secretion in human breast carcinoma. En-do Rev 1987; 8: 29–43
   PubMed Web of Science ®Google Scholar
• Dickson R. B., Huff K. K., Spencer E. M., et al. Induction of epidermal growth factor-related polypeptides by estradiol in MCF-7 human breast cancer cells. Endocrinology 1986; 118: 138–142
   PubMed Web of Science ®Google Scholar
• Defize L., Mummery C., Moolenaar W., et al. Antiraceptor antibodies in the study of EGF-receptor interaction. Cell Differ 1987; 20: 87–102
   PubMedGoogle Scholar
• Sato J. D., Kawamoto T., Le A. D., et al. Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. Mol Biol Med 1983; 1: 511–529
   PubMedGoogle Scholar
• Kawamoto T., Sato J. D., Le A., et al. Growth stimulation of A431 cells by epidermal growth factor: Identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci (USA) 1983; 80: 1337–1341
   PubMed Web of Science ®Google Scholar
• Sunada H., Magun G. E., Mendelsohn J., et al. Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation. Proc Natl Acad Sci (USA) 1986; 83: 3825–3829
   PubMed Web of Science ®Google Scholar
• Gill G. N., Kawamoto T., Cochet C., et al. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonist of epidermal growth factor-stimulated tyrosine protein kinase activity. J Biol Chem 1984; 259: 7755–7760
   PubMed Web of Science ®Google Scholar
• Kawamoto T., Medelsohn J., Le A., et al. Relation of epidermal growth factor receptor concentration of growth of human epidermoidcarcinoma A431 cells. J Biol Chem 1984; 259: 7761–7766
   PubMed Web of Science ®Google Scholar
• Masui H., Kawamoto T., Sato J. D., et al. Growth inhibition of human tumor cells in athymic mice by anticpidermal growth factor receptor monoclonal antibodies. Cancer Res 1984; 44: 1002–1007
   PubMed Web of Science ®Google Scholar
• Aboud-Pirak E., Hurwitz E., Pirak M., et al. Efficacy of antibodies of epidermal growth factor receptor against KB carcinoma in vitro and in nude mice. J Natl Cancer Inst 1988; 80: 1605–1611
   PubMed Web of Science ®Google Scholar
• Filmus J., Trent J. M., Pollack M. N., et al. Epidermal growth factor receptor-gene-amplified MDA-468 breast cancer cell line and its nonamplified variants. Mol Cell Bol 1987; 7: 251–257
   PubMed Web of Science ®Google Scholar
• Santon J. B., Cronin M. T., MacLeod C. L., et al. Effects of epidermal growth factor receptor concentration on tumorigenicity of A431 cells in nude mice. Cancer Res 1986; 46: 4701–4705
   PubMed Web of Science ®Google Scholar
• Ozawa S., Ueda M., Ando N., et al. Simulation by EGF of the growth of EGF receptor-hyperproducing tumor cells in athymic mice. Int J Cancer 1987; 40: 706–710
   PubMed Web of Science ®Google Scholar
• Bjorge J., Paterson A., Kudlow J. Phorbol ester or epidermal growth factor stimulates the concurrent accumulation of mRNA for the EGF receptor and its ligand transforming growth factor-alpha in a breast cancer cell line. J Biol Chem. 1989; 264: 4021–4027
   PubMed Web of Science ®Google Scholar
• Kozma S., Boggard M., Buser K., et al. The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MD-231. Nucleic Acids Res 1987; 15: 5963–5970
   PubMed Web of Science ®Google Scholar
• Kraus M., Yuasa Y., Aaronson S. A position 13-activated H-ras oncogene in all Hs578T mammary carcinowcoma cells but not normal mammary cells of the same patient. Proc Natl Acad Sci (USA) 1984; 81: 5384–5388
   PubMed Web of Science ®Google Scholar
• Arteaga C., Coronado E., Osborne C. K. Blockade of the epidermal growth factor receptor inhibits transforming growth factor alpha induced but not estrogen induced growth of hormonedependent human breast cancer. Mol Endocrinol 1988; 2: 1064–1069
   PubMed Web of Science ®Google Scholar
• Himmelweit B. (4.): The Collected Papers of Paul Ehrlich. Pergamon Press, Elmsford, NY 1975
   Google Scholar
• Pastan I., Willingham M. C., FitzGerald D. JP. Immunotoxins. Cell 1986; 47: 641–648
   PubMed Web of Science ®Google Scholar
• Foon K. A. Biological response modifiers: the new immunotherapy. Cancer Res 1989; 49: 1621–1639
   PubMed Web of Science ®Google Scholar
• Masui H., Kamrath H., Apell G., et al. Cytotoxicity against human-tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant rich A chain. Cancer Res 1989; 49: 3482–3488
   PubMed Web of Science ®Google Scholar
• Taetle R., Honeysett M., Houston L. L. Effects of anti-epidermal growth factor (EGF) receptor antibodies and an anti-EGF recep tor recombinant-ricin A chain immunownjugate on growth of human cells. J Natl Cancer Inst, 80: 1053–1059
   PubMed Web of Science ®Google Scholar
• FitzGerald D., Pastan I. Targded toxin therapy for the treatment of cancer. J Natl Cancer Inst 1989; 81: 1455–1463
   PubMed Web of Science ®Google Scholar
• Siegall C. B., Chaudhary V. K., FitzGerald D. J., et al. Functional analysis of domains II, Ib, and III of Pseudomom exotoxin. J Biol Chem 1989; 264: 14256–14261
   PubMed Web of Science ®Google Scholar
• Allured V. S., Collier R. J., Carrol S. F., et al. Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-angstrom resolution. Proc Natl Acad Sci (USA) 1986; 83: 1320–1324
   PubMed Web of Science ®Google Scholar
• Hwang J., FitzGerald D. J., Adhya S., et al. Functional domains of Pseudomonos exotoxin identilied by deletion analysis of the gene expressed in E. coli. Cell 1987; 48: 129–136
   PubMed Web of Science ®Google Scholar
• Kondo T., FitzGerald D., Chaudbary V., et al. Activity of immunotoxins constructed with modified Pseudomonas extoxin A lacking the cell recognition domain. J Biol Chem. 1988; 263: 9470–9475
   PubMed Web of Science ®Google Scholar
• Siegall C. B., Xu Y-H, Chaudhary V. K., et al. Cytotoxic activities of a fusion protein comprised of TGFa and Pseudomonas exotoxin. FASEB J 1989; 3: 2647–2653
   PubMed Web of Science ®Google Scholar